MR编号 | NL/H/1707/002 |
---|
药品名称 | Amoxicillin/Clavulanic acid Aurobindo 875/125 mg |
---|
活性成分 | - Amoxicillin trihydrate 875.0 mg
- Clavulanic acid potassium salt 125.0 mg
|
---|
剂型 | Film-coated tablet |
---|
上市许可持有人 | Aurobindo Pharma B.V.
Baarnsche Dijk 1
3741 LN Baarn
Netherlands |
---|
参考成员国 - 产品名称 | Netherlands (NL) Amoxicilline/Clavulaanzuur Aurobindo 875 mg/125 mg, filmomhulde tabletten |
---|
互认成员国 - 产品名称 | - Germany (DE)
Amoxi-Clavulan Aurobindo 875 mg/ 125 mg Filmtabletten - Austria (AT)
Amoxicillin/Clavulansäure Aurobindo 875 mg/125 mg Filmtabletten - Spain (ES)
- Italy (IT)
- Sweden (SE)
Amoxicillin/Clavulanic acid Aurobindo - Romania (RO)
Amoxicilină / Acid clavulanic Aurobindo 875 mg/125 mg comprimate filmate - Denmark (DK)
|
---|
许可日期 | 2009/09/22 |
---|
最近更新日期 | 2025/01/28 |
---|
药物ATC编码 | - J01CR02 amoxicillin and beta-lactamase inhibitor
|
---|
申请类型 | - TypeLevel1:Abridged
- TypeLevel2:Additional Strength/Form
- TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
- TypeLevel4:Chemical Substance
- TypeLevel5:Prescription Only
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|